NeuBase Therapeutics, Inc. NBSE
0.38 +0.38
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Sep 30, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 | FY 2019 Sep 30, 2019 | FY 2018 Sep 30, 2018 |
|---|---|---|---|---|---|
| 33.32M | 26.57M | 17.07M | 25.51M | 15.13M | |
| 21.45M | 14.36M | 6.95M | 16.41M | 4.32M | |
| 11.87M | 12.20M | 10.12M | 9.10M | 3.63M | |
| -33.32M | -26.57M | -17.07M | -25.51M | -15.13M | |
| 24.05K | 32.33K | 7.69K | 128.95K | -74.47K | |
| -33.78M | -25.41M | -17.38M | -26.13M | -13.24M | |
| -33.78M | -25.41M | -17.38M | -26.13M | -13.24M | |
| -33.78M | -25.41M | -17.38M | -26.13M | -13.24M | |
| -33.78M | -25.41M | -17.38M | -26.13M | -13.24M | |
| -20.80 | -18.60 | -17.80 | -63.20 | -92.00 | |
| -20.80 | -18.60 | -17.80 | -63.20 | -92.00 | |
| -20.80 | -18.60 | -17.80 | -63.20 | -92.00 | |
| -33.75M | -25.38M | -17.38M | -26.00M | -13.31M | |
| -33.75M | -25.38M | -17.38M | -26.00M | -13.31M | |
| 1.62M | 1.37M | 981.01K | 413.58K | 141.00K | |
| 1.62M | 1.37M | 981.01K | 413.58K | 141.00K |